BPG is committed to discovery and dissemination of knowledge
Retrospective Cohort Study
©The Author(s) 2025.
World J Psychiatry. Oct 19, 2025; 15(10): 107147
Published online Oct 19, 2025. doi: 10.5498/wjp.v15.i10.107147
Table 1 Demographic and clinical characteristics of the study population, n (%)
Characteristic
All participants (n = 200)
With depression (n = 85)
Without depression (n = 115)
P value
With anxiety (n = 102)
Without anxiety (n = 98)
P value
Age (year), mean ± SD32.7 ± 6.433.2 ± 6.132.3 ± 6.60.32532.5 ± 6.332.9 ± 6.50.652
BMI (kg/m2), mean ± SD24.6 ± 4.325.3 ± 4.624.1 ± 4.00.047a25.0 ± 4.524.2 ± 4.00.182
Education level0.089-0.134
Secondary or lower42 (21.0)23 (27.1)19 (16.5)26 (25.5)16 (16.3)
College114 (57.0)43 (50.6)71 (61.7)53 (52.0)61 (62.2)
Postgraduate44 (22.0)19 (22.4)25 (21.7)23 (22.5)21 (21.4)
Marital status0.762-0.518
Single62 (31.0)25 (29.4)37 (32.2)34 (33.3)28 (28.6)
Married122 (61.0)52 (61.2)70 (60.9)59 (57.8)63 (64.3)
Divorced/separated16 (8.0)8 (9.4)8 (7.0)9 (8.8)7 (7.1)
Employment status0.018a-0.042a
Employed138 (69.0)51 (60.0)87 (75.7)63 (61.8)75 (76.5)
Unemployed46 (23.0)25 (29.4)21 (18.3)29 (28.4)17 (17.3)
Student16 (8.0)9 (10.6)7 (6.1)10 (9.8)6 (6.1)
Disease duration (year), mean ± SD6.8 ± 4.57.5 ± 4.76.3 ± 4.30.0597.2 ± 4.66.4 ± 4.30.195
rASRM stage0.007b-0.013a
Stage I (minimal)28 (14.0)8 (9.4)20 (17.4)10 (9.8)18 (18.4)
Stage II (mild)42 (21.0)13 (15.3)29 (25.2)17 (16.7)25 (25.5)
Stage III (moderate)76 (38.0)34 (40.0)42 (36.5)42 (41.2)34 (34.7)
Stage IV (severe)54 (27.0)30 (35.3)24 (20.9)33 (32.4)21 (21.4)
Pain severity (VAS), mean ± SD6.4 ± 2.17.3 ± 1.85.7 ± 2.0< 0.001c7.0 ± 1.95.7 ± 2.0< 0.001c
Previous treatments
Analgesics178 (89.0)78 (91.8)100 (87.0)0.28393 (91.2)85 (86.7)0.320
Hormonal therapy142 (71.0)64 (75.3)78 (67.8)0.25076 (74.5)66 (67.3)0.261
Surgery168 (84.0)74 (87.1)94 (81.7)0.30788 (86.3)80 (81.6)0.364
Infertility62 (31.0)32 (37.6)30 (26.1)0.07837 (36.3)25 (25.5)0.098


Write to the Help Desk